Canakinumab
Canakinumab (ACZ885) is a recombinant human IL-1β-targeting monoclonal antibody that inhibits human and chorioallantoic monkey IL-1β with IC50 values of 43.6 and 40.8 pM, respectively. It exhibits anti-inflammatory activity by neutralizing IL-1β signaling, and it has been used for the treatment of gout and coronary artery disease.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
IL Receptor
CAS Number
914613-48-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7151907 Inquire
Rabbit anti-Oryza sativa subsp. japonica (Rice) Os10g0114500 Polyclonal Antibody
Ask
View Details 
MBS6334917-01 0.2 mL
PLEKHO2, NT (PLEKHO2, PLEKHQ1, Pleckstrin homology domain-containing family O member 2, Pleckstrin homology domain-containing family Q member 1) (APC)
Ask
View Details MBS6334917-02 5x 0.2 mL
PLEKHO2, NT (PLEKHO2, PLEKHQ1, Pleckstrin homology domain-containing family O member 2, Pleckstrin homology domain-containing family Q member 1) (APC)
Ask
View Details